Primary Site >> Colorectal Cancer
Gene >> CRY2
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Chronotherapy for cancer. PMID: 14572683 |
Ref: Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. PMID: 21380491 Ref: Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. PMID: 22080729 |
Ref: Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer. PMID: 25855785 Ref: Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer. PMID: 26617816 |
Ref: Deregulated expression of cryptochrome genes in human colorectal cancer. PMID: 26768731 Ref: Optogenetic activation of axon guidance receptors controls direction of neurite outgrowth. PMID: 27052670 Ref: Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients. PMID: 27103825 Ref: Disruption of clock gene expression in human colorectal liver metastases. PMID: 27492458 |
Ref: miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer. PMID: 28749470 |
Ref: Integrated analysis of gene expression signatures associated with colon cancer from three datasets. PMID: 29408621 Ref: Expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates with location of tumor differently. PMID: 29940771 Ref: Sex-dependent correlation between survival and expression of genes related to the circadian oscillator in patients with colorectal cancer. PMID: 29953268 |